In addition to merlin, CRL4 can also upregulate the mTOR pathway through promoting ubiquitination and degradation of tuberous sclerosis 2 (TSC2), a tumor suppressor, that forms a complex with TSC1 which can inhibit the mTOR signaling in a RheB-dependent manner [100, 101]. This evidence concerns the gene TSC2 and neoplasm.